University of Copenhagen:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Copenhagen - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10701
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Copenhagen (UCPH) is a university and research institution that offers educational and research programs and services. The university’ services include graduate and undergraduate courses, research programs, master’s programs, continuing education services, online courses, international students courses, research databases, PhD programs and business collaborations courses. It also provides nanoscience and technology, chemical and biochemical engineering, applied cultural analysis, business administration and innovation in health care, environmental and natural resource economics, professional master programs, specialized and customized courses. UCPH’s master’s programs comprise master of companion animal clinical science, master of disaster management, master of headache disorders, master of industrial drug development, north sea energy law program and master of medicines regulatory affairs. The university provides its services through its departments and facilities. UCPH is headquartered in Copenhagen, Denmark.

University of Copenhagen – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Copenhagen, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Copenhagen, Medical Devices Deals, 2012 to YTD 2018 10
University of Copenhagen, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
University of Copenhagen, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
CiMaas Enters into Agreement with Cancer Research Technology and University of Copenhagen 12
Licensing Agreements 13
ADCendo Enters into Licensing Agreement with University of Copenhagen and Capital Region of Denmark 13
Equity Offering 14
Antag Therapeutics Spin Out from University of Copenhagen 14
University of Copenhagen – Key Competitors 15
University of Copenhagen – Key Employees 16
University of Copenhagen – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Government and Public Interest 19
Oct 23, 2018: Research team receives new funding for continued research into the blood-brain barrier 19
Sep 20, 2018: Insulin Shows Great Potential Against Chronic Colitis 20
Aug 29, 2018: New strategic funding to metabolic research at the University of Copenhagen 21
Aug 17, 2018: Scientists create new technology and solve a key puzzle for cellular memory 23
Jul 25, 2018: New enzyme discovery may help improve drugs against cancer, diabetes and obesity 24
Jun 29, 2018: Enzyme may get key role in drug design for breast cancer and brain condition 25
May 14, 2018: Researchers uncover up to 100 potential drug targets for cancer 26
Apr 16, 2018: New Study Discovers Cancer-Relevant Protein Shield 28
Jan 23, 2018: Nordic collaboration receives 35 million DKK for personalised medicine 29
Dec 15, 2017: Distinct human mutations can alter the effect of medicine 30
Dec 14, 2017: Cellular Reprogramming fuels Wound Healing in the Intestine 31
Dec 14, 2017: New research linking cancer-inhibiting proteins to cell antennae 32
Nov 30, 2017: New Vaccine Technique Effectively Fights Breast Cancer in Mice 33
Nov 30, 2017: Oxygen Treatment Makes Antibiotics Work Again 34
Nov 08, 2017: Nanoshells could deliver more chemo with fewer side effects 35
Oct 31, 2017: University of Copenhagen: Researchers map trends in drug development 37
Sep 25, 2017: A new role for Insulin as a Vital Factor in Maintaining Stem Cells 38
Aug 24, 2017: New Ambitious Research Programme Receives DKK 100 million for Research into Leukaemia and New Treatment 39
Aug 23, 2017: Scientists discover common obesity and diabetes drug reduces rise in brain pressure 40
Jul 06, 2017: A New Molecular Scissors Act Like A GPS to Improve Genome Editing 41
May 17, 2017: Researchers take an important step toward an HIV vaccine 42
Apr 17, 2017: Novo Nordisk Foundation Grant 43
Mar 30, 2017: Eurostars funding for novel Zika vaccine 44
Feb 08, 2017: Oxygen under pressure increases effect of antimicrobial agents 45
Product News 46
Sep 26, 2018: New allergy vaccine for hay fever shows promising results 46
Mar 03, 2017: Bioneer: In the Forefront of Developing New Human Cell Models for Neurodegenerative Diseases 47
Jan 31, 2018: New technology: Edible QR code can be the medicine of the future 48
Other Significant Developments 49
Sep 26, 2018: Study: New allergy vaccine for hay fever shows promising results 49
Sep 12, 2018: Researchers uncover previously unstudied cancer enzyme 50
Sep 12, 2018: New method promises fewer side-effects from cancer drugs 51
Jun 18, 2018: Study Examines First Birth Cohort to Receive HPV Vaccine: The Vaccine Works 52
May 30, 2018: Study Offers New Hope for the Fight Against Genetically Determined Obesity 54
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
University of Copenhagen, Pharmaceuticals & Healthcare, Key Facts 2
University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Copenhagen, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Copenhagen, Deals By Therapy Area, 2012 to YTD 2018 9
University of Copenhagen, Medical Devices Deals, 2012 to YTD 2018 10
University of Copenhagen, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
CiMaas Enters into Agreement with Cancer Research Technology and University of Copenhagen 12
ADCendo Enters into Licensing Agreement with University of Copenhagen and Capital Region of Denmark 13
Antag Therapeutics Spin Out from University of Copenhagen 14
University of Copenhagen, Key Competitors 15
University of Copenhagen, Key Employees 16
University of Copenhagen, Subsidiaries 17

List of Figures
University of Copenhagen, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Copenhagen, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Copenhagen, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[University of Copenhagen:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inoviem Scientific SAS-製薬・医療分野:企業M&A・提携分析
    Summary Inoviem Scientific SAS (Inoviem) is a contract research biotechnology company that offers preclinical and clinical services. The company develops solutions in the field of drug target interaction analysis and drug development. Its technologies include physiological intermolecular modulation …
  • ARCA biopharma Inc (ABIO):企業の財務・戦略的SWOT分析
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Physiomics Plc (PYC):製薬・医療:M&Aディール及び事業提携情報
    Summary Physiomics plc (Physiomics) is a computational systems biology services company. It offers Virtual Tumour, which optimizes the dosing and scheduling of oncology drugs in pre-clinical trials, cardiac toxicity services through its EasyAP, a Web-based simulation and analysis tool. It also offer …
  • The British Land Company PLC:企業の戦略・SWOT・財務分析
    The British Land Company PLC - Strategy, SWOT and Corporate Finance Report Summary The British Land Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Blockchain Power Trust (TEP.UN):電力:M&Aディール及び事業提携情報
    Summary Blockchain Power Trust is an alternative energy company that offers power solutions. The company's services include wind energy solutions, power generations, transmission, supplying, and distribution services. It also provides solar energy solutions, and hydropower energy solutions, among ot …
  • Oversea-Chinese Banking Corp Ltd:企業の戦略・SWOT・財務情報
    Oversea-Chinese Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Oversea-Chinese Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Banca Carige SpA (CRG):企業の財務・戦略的SWOT分析
    Banca Carige SpA (CRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Abg Sundal Collier Holding Asa
    Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report Summary Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Invenergy LLC:企業の戦略的SWOT分析
    Invenergy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • FortisBC Inc:企業の戦略的SWOT分析
    FortisBC Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Denali Therapeutics Inc:企業のM&A・事業提携・投資動向
    Denali Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Denali Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • The People’s Insurance Company (Group) of China Limited:戦略・SWOT・企業財務分析
    The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report Summary The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • OUE Ltd:企業の戦略・SWOT・財務情報
    OUE Ltd - Strategy, SWOT and Corporate Finance Report Summary OUE Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • AdAlta Ltd (1AD):製薬・医療:M&Aディール及び事業提携情報
    Summary AdAlta Ltd (AdAlta), formerly AdAlta Pty Ltd, is a biotechnology company that discovers and develops new class of protein therapeutics for wide range of human diseases. The company's lead i-body candidate, AD-114, is being developed for the treatment of idiopathic pulmonary fibrosis and othe …
  • Dermira Inc (DERM):製薬・医療:M&Aディール及び事業提携情報
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • Swarovski AG:企業の戦略・SWOT・財務分析
    Swarovski AG - Strategy, SWOT and Corporate Finance Report Summary Swarovski AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • IRWIN Industrial Tool Co:企業の戦略的SWOT分析
    IRWIN Industrial Tool Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • MPI Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MPI Research Inc (MPI) is a drug development contract research organization that offers contracted scientific research services. The organization’s services comprise drug safety services, discovery sciences solutions, bioanalytical and analytical solutions, surgical services and medical devi …
  • Primark Stores Ltd:企業の戦略・SWOT・財務情報
    Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Botswana Power Corporation:発電所・企業SWOT分析
    Botswana Power Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆